全文获取类型
收费全文 | 5766篇 |
免费 | 344篇 |
国内免费 | 41篇 |
专业分类
耳鼻咽喉 | 47篇 |
儿科学 | 96篇 |
妇产科学 | 35篇 |
基础医学 | 783篇 |
口腔科学 | 83篇 |
临床医学 | 364篇 |
内科学 | 1603篇 |
皮肤病学 | 108篇 |
神经病学 | 477篇 |
特种医学 | 218篇 |
外科学 | 993篇 |
综合类 | 37篇 |
一般理论 | 3篇 |
预防医学 | 130篇 |
眼科学 | 111篇 |
药学 | 365篇 |
中国医学 | 23篇 |
肿瘤学 | 675篇 |
出版年
2024年 | 6篇 |
2023年 | 68篇 |
2022年 | 111篇 |
2021年 | 238篇 |
2020年 | 145篇 |
2019年 | 194篇 |
2018年 | 254篇 |
2017年 | 130篇 |
2016年 | 156篇 |
2015年 | 163篇 |
2014年 | 210篇 |
2013年 | 247篇 |
2012年 | 424篇 |
2011年 | 495篇 |
2010年 | 248篇 |
2009年 | 204篇 |
2008年 | 339篇 |
2007年 | 358篇 |
2006年 | 352篇 |
2005年 | 337篇 |
2004年 | 312篇 |
2003年 | 274篇 |
2002年 | 249篇 |
2001年 | 51篇 |
2000年 | 37篇 |
1999年 | 43篇 |
1998年 | 37篇 |
1997年 | 32篇 |
1996年 | 26篇 |
1995年 | 26篇 |
1994年 | 45篇 |
1993年 | 32篇 |
1992年 | 35篇 |
1991年 | 22篇 |
1990年 | 23篇 |
1989年 | 20篇 |
1988年 | 20篇 |
1987年 | 33篇 |
1986年 | 31篇 |
1985年 | 15篇 |
1984年 | 13篇 |
1983年 | 16篇 |
1982年 | 8篇 |
1981年 | 5篇 |
1979年 | 6篇 |
1973年 | 7篇 |
1971年 | 5篇 |
1970年 | 5篇 |
1967年 | 8篇 |
1966年 | 6篇 |
排序方式: 共有6151条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
Hisato Takagi Toshiyuki Tanabashi Norikazu Kawai Takuya Umemoto 《European journal of cardio-thoracic surgery》2007,32(2):400; author reply 400-400; author reply 401
6.
7.
M Asakawa S Wada N Hayahara R Yayumoto T Kishimoto M Maekawa Y Morikawa J Kawakita M Umeda A Horii 《Hinyokika kiyo. Acta urologica Japonica》1990,36(11):1361-1369
Estramustine phosphate disodium (Estracyt) was used in the treatment of 38 patients with prostatic carcinoma for at least 1 year. Of these patients 37 patients were treated with Estracyt as primary treatment and 1 patient had been treated with another antiandrogenic therapy before the Estracyt treatment. Estracyt was given orally in a dose of 560 mg/day in divided oral doses. The clinical evaluation was done for the change of PAP, the relapse rate, the survival rate and the side effect. Among 22 cases which had shown abnormally high PAP values before the treatment started, the values decreased or normalized in 21 cases (95.5%) in the first year of administration of Estracyt. In 6 cases, however, the values increased again in the second year or later. Relapse was observed in 10 (26.3%) out of 38 cases. Relapse rate was 2.6%, 51.7%, and 51.7%, at the first, third, and fifth year, respectively. Survival rate was 97.4% at the first year, 88.5% at the third year, and 68.8% at the fifth year for the follow-up study. Side effects were observed in 14 (36.8%) out of 38 cases. The main side effect was gynecomastia. Gastro-intestinal disturbance and edema were also observed. However, there were only 2 cases (5.2%) in which administration of Estracyt had to be discontinued. 相似文献
8.
Nobuyuki Takemura Yasuhiko Sugawara Takuya Hashimoto Nobuhisa Akamatsu Yoji Kishi Sumihito Tamura Masatoshi Makuuchi 《Liver transplantation》2005,11(3):356-360
The incidence of hepatic venous stenosis is higher in partial liver transplantation. New methods for hepatic venous reconstruction in left liver transplantation, which secure wide anastomosis, were devised and are reported here. In the graft, the right side of the middle hepatic vein or the left side of the left hepatic vein was cut longitudinally and a rectangular-shaped vein patch was attached for venoplasty. In the recipient, after the left and middle hepatic veins were joined, the right side of the middle hepatic vein was cut toward the closed right hepatic vein, making a horizontal cavotomy for anastomosis. Of 92 patients who underwent conventional hepatic vein reconstruction, 3 were complicated by hepatic venous stenosis (median follow-up 43 months). By contrast, there were no hepatic vein complications in the 20 patients who underwent the new technique (7 months). The current method appears to be technically feasible for outflow reconstruction in left liver graft transplantation. 相似文献
9.